or Try an Advanced Search...

    Ocular Hypertension Stocks List

    Symbol Grade Name % Change
    ABBV D AbbVie Inc. -1.70
    BLCO F Bausch + Lomb Corporation -1.75
    OCUL D Ocular Therapeutix, Inc. 2.59
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Medical Instruments & Supplies
    Related Stock Lists: Cataract Surgery Cataracts Glaucoma Treatment Of Glaucoma Adalimumab Advanced Prostate Cancer Allergic Conjunctivitis Allergology Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Clinical Trial Combination Drugs Conjunctivitis Constipation Contact Lenses Cornea Crohn's Disease

    Related ETFs - A few ETFs which own one or more of the above listed Ocular Hypertension stocks.

    Symbol Grade Name Weight
    MEDI C Harbor Health Care ETF 9.87
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ C Global X Robotics & Artificial Intelligence Thematic ETF 9.04
    GRID B First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 8.3
    MEDX F Horizon Kinetics Medical ETF 7.88
    View all Ocular Hypertension ETFs...
    Compare ETFs
    Compare BOTZ to MEDX Compare HDLB to BOTZ Compare HDLB to GRID

        Ocular Hypertension Stocks Recent News

        Date Stock Title
        May 2 ABBV The top pharmaceutical companies by R&D expenditure
        May 1 ABBV BeiGene, AbbVie patent spat to get trial from USPTO appeals board
        May 1 ABBV CVS stock plunges after earnings numbers one analyst 'did not even believe'
        May 1 BLCO Bausch + Lomb Corporation (BLCO) Q1 2024 Earnings Call Transcript
        May 1 BLCO Bausch & Lomb Corp (BLCO) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Net Loss Widening
        May 1 OCUL Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
        May 1 BLCO Bausch + Lomb GAAP EPS of -$0.48, revenue of $1.1B
        May 1 BLCO Bausch + Lomb Announces First-Quarter 2024 Results
        Apr 30 BLCO Bausch + Lomb Q1 2024 Earnings Preview
        Apr 30 ABBV Trials to watch: Four ALS drugs to keep an eye on
        Apr 30 ABBV AbbVie (ABBV) Could Be a Great Choice
        Apr 30 ABBV AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
        Apr 30 ABBV Earnings Beat: AbbVie Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
        Apr 29 ABBV AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
        Apr 29 ABBV AbbVie: The Inevitable Is Happening
        Apr 29 BLCO Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
        Apr 29 ABBV Unveiling AbbVie's Winning Strategy In Pharmaceutical Innovation (Rating Upgrade)
        Apr 29 ABBV Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 29 BLCO Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 28 ABBV Dividend Stock Portfolio For Income: Top 15 Stocks
        Related Industries: Biotechnology Drug Manufacturers - Major Medical Instruments & Supplies
        Related Stock Lists: Cataract Surgery Cataracts Glaucoma Treatment Of Glaucoma Adalimumab Advanced Prostate Cancer Allergic Conjunctivitis Allergology Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chronic Idiopathic Constipation Clinical Trial Combination Drugs Conjunctivitis Constipation Contact Lenses Cornea Crohn's Disease
        Ocular Hypertension

        Browse All Tags